FTT
Click for more information
0.00% 0.5¢ factor therapeutics limited

Nov 14 (Reuters) - Factor Therapeutics Ltd (FTT) : PHASE 2...

  1. Hot News
    68,069 Posts.
    lightbulb Created with Sketch. 460
    clock Created with Sketch.
    14/11/18
    09:30
    Post #: 36495373

    Nov 14 (Reuters) - Factor Therapeutics Ltd (FTT) :

    • PHASE 2 TRIAL OF VF001 FOR TREATMENT OF VENOUS LEG ULCER FAILED TO MEET ALL ENDPOINTS
    • ONGOING DEVELOPMENT OF VF001 FOR ALL INDICATIONS HALTED
    • ROSALIND WILSON WILL STEP DOWN AS CEO IN DUE COURSE
    • TO LIMIT FURTHER ACTIVITY TO MAINTAINING EXISTING INTELLECTUAL PROPERTY PORTFOLIO

    Source text:(bit.ly/2DlMfa3)

    (([email protected];))

    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Significant milestone reached in Zimbabwe's oil and gas exploration industry as Invictus Energy moves closer to execution
right-arrow Created with Sketch.
NEWS Share Purchase Plan by robotic technology company now complete
right-arrow Created with Sketch.
MKG Encouraging results for Raiden as Pegmatite extensions confirmed
right-arrow Created with Sketch.
NEWS High grade drill results discovered at CODA North
right-arrow Created with Sketch.
NEWS MTM and Indium form strategic collaboration for recovering Gallium and Germanium
right-arrow Created with Sketch.
NEWS Experienced CEO appointed to Indiana Resources
right-arrow Created with Sketch.
watchlist Created with Sketch. Add FTT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.